Patents Assigned to Novartis Finance Corporation
  • Patent number: 5998636
    Abstract: Substituted N-phenyl- and N-heteroarylalkylcarbamates of the formula I ##STR1## in which Q is a group ##STR2## R is halogen, trifluoromethyl, cyano, nitro or C.sub.1 -C.sub.3 haloalkoxy;Z is hydrogen or halogen; orZ and R together in the 2- and 3-position of the phenyl ring form a group --OCF.sub.2 O--;R.sub.1 is C.sub.1 -C.sub.5 alkyl;R.sub.2, R.sub.3, R.sub.4 and R.sub.5, independently of one another, are hydrogen, methyl or ethyl;X is oxygen, sulfur, --SO-- or --SO.sub.2 --;Y is hydrogen, halogen, C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 haloalkyl, C.sub.1 -C.sub.3 alkoxy or cyano;n is 0, 1 or 2;n.sub.1 is 0 or 1; andm is 0 or 1,with the proviso that m is 1 if Q is group (1) or (2);and the diastereomers and enantiomers thereof,exhibit pre- and post-emergence herbicidal properties. The preparation of these compounds and their use as herbicidally active ingredients are described.
    Type: Grant
    Filed: August 4, 1998
    Date of Patent: December 7, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Hermann Rempfler, Fredrik Cederbaum, Felix Spindler, Willy Urs Lottenbach
  • Patent number: 5990383
    Abstract: The present invention is drawn to pesticidal strains and proteins. Bacillus strains which are capable of producing pesticidal proteins and auxiliary proteins during vegetative growth are provided. Also provided are the purified proteins, nucleotide sequences encoding the proteins and methods for using the strains, proteins and genes for controlling pests.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 23, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Gregory W. Warren, Michael G. Koziel, Martha A. Mullins, Gordon J. Nye, Brian Carr, Nalini M. Desai, Kristy Kostichka, Nicholas B. Duck, Juan J. Estruch
  • Patent number: 5981844
    Abstract: Novel plant proteins (SAFPs) which synergize the activity of antifungal antibiotics are identified. SAFPs are demonstrated to synergize antifungal antibiotics, such as nikkomycins, polyoxins and amphotericins. SAFPs alone also display antifungal activity against several species of fungi, including strains of Candida, Trichoderma, Neurospora and strains of the plant pathogens Fusarium, Rhizoctonia and Chaetomium. Synergistic antifungal compositions containing SAFP and antifungal antibiotics are provided. In particular, synergistic compositions of corn-SAFP (zeamatin), sorghum-SAFP (sormatin) or oat-SAFP (avematin) and nikkomycin are found to be effective as antifungal compositions, especially against the opportunistic human pathogen Candida albicans. Method for employing SAFPs and synergistic compositions containing them for the inhibition of fungi are provided. In addition, a method for purifying SAFP from grain meal is provided.
    Type: Grant
    Filed: December 19, 1997
    Date of Patent: November 9, 1999
    Assignees: Novartis Finance Corporation, University Research Corporation
    Inventors: Walden K. Roberts, Claude P. Selitrennikoff, Bridget E. Laue, Sharon L. Potter
  • Patent number: 5981585
    Abstract: Compounds of the formula I ##STR1## and the isomers thereof, in which either a) X is an N atom and Y is OR.sub.11 or N(R.sub.12)R.sub.13, orb) X is CH and Y is OR.sub.11,and in which furthermore:R.sub.11 is C.sub.1 -C.sub.4 alkyl;R.sub.12 and R.sub.13, independently, are hydrogen or C.sub.1 -C.sub.4 alkyl;A is an O atom or the group NR.sub.4 ; and whereinR.sub.1, R.sub.2 and R.sub.3 are as defined herein, are pesticidal active ingredients. They can be used for pest control, in particular as microbicides, insecticides and acaricides in agriculture, horticulture and in the hygiene sector.
    Type: Grant
    Filed: November 12, 1997
    Date of Patent: November 9, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Hugo Ziegler, Stephan Trah, Saleem Farooq, Rene Zurfluh
  • Patent number: 5976880
    Abstract: In a tubular pressure chamber a drop of a DNA solution with gold particles suspended therein is atomized at the opening of a cannula by a pressure impact. The fog droplets containing the gold particles and the DNA entrained by them, are pressured by the pressure impact through a restriction at the end of the pressure chamber and thereby accelerated and focused. They subsequently traverse in free flight an evacuated specimen chamber and impact in a narrowly limited target area with a predetermined pulse, cells fixed on a holder, thereby penetrating them.
    Type: Grant
    Filed: December 18, 1990
    Date of Patent: November 2, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Christof Sautter, Heinz Waldner, Ingo Potrykus
  • Patent number: 5977182
    Abstract: Compounds of formula (I), wherein Y is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, OH, CN, NO.sub.2, Si(CH.sub.3).sub.3, CF.sub.3 or halogen, and T is a group (a) or (b), and wherein the remaining substituents have the following definitions: X is O, S or NR.sub.13 ; A is O or NR.sub.4 ; R.sub.1 is hydrogen, C.sub.1 -C.sub.4 alkyl, halo-C.sub.1 -C.sub.4 alkyl, cyclopropyl, C.sub.1 -C.sub.4 alkoxymethyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkylthio or cyano; R.sub.2 is hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.6 cycloalkyl, cyano unsubstituted or substituted C.sub.1 -C.sub.6 alkoxycarbonyl, unsubstituted or substituted di(C.sub.1 -C.sub.6 alkyl)aminocarbonyl, unsubstituted or substituted C.sub.1 -C.sub.6 alkyl-S(O).sub.q, unsubstituted or substituted aryl-S(O).sub.q, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclylcarbonyl or unsubstituted or substituted phenyl; and R.sub.
    Type: Grant
    Filed: May 1, 1997
    Date of Patent: November 2, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Rene Zurfluh, Hugo Ziegler, Stephan Trah
  • Patent number: 5965613
    Abstract: The present invention relates to aromatic compounds, namely substituted methyl 2-phenyl-3-methoxy-acrylates of the general formula ##STR1## where X represents an aldimino or ketimino group, in particular a group ##STR2## where R.sup.1 and R.sup.2 independently of one another denote hydrogen, C.sub.1-12 -alkyl, C.sub.1-4 -haloalkyl, and C.sub.1-4 -alkoxy-C.sub.1 -C.sub.4 -alcyl.
    Type: Grant
    Filed: September 22, 1997
    Date of Patent: October 12, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Hans P. Isenring, Stephan Trah, Bettina Drechsel
  • Patent number: 5955484
    Abstract: Plant-protecting active ingredient mixtures having synergistically enhanced action, wherein component I is a compound having plant-immunising action of formula I ##STR1## wherein Z is CN, COOH or a salt thereof, CO--OC.sub.1 -C.sub.4 alkyl or CO--SC.sub.1 -C.sub.4 alkyl;and wherein component II is a compound selected from the groupA) 4-?3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl!morpholine ("dimethomorph");B) 5-methyl-1,2,4-triazolo?3,4-b!?1,3!benzothiazole ("tricyclazole"); andC) 3-allyloxy-1,2-benzothiazole-1,1-dioxide ("probenazole").
    Type: Grant
    Filed: April 28, 1998
    Date of Patent: September 21, 1999
    Assignee: Novartis Finance Corporation
    Inventor: Wilhelm Ruess
  • Patent number: 5955362
    Abstract: The present invention is drawn to the production of fertile transformed wheat plants. The method involved subjecting wheat tissues to high velocity microprojectile bombardment, selecting for transformed cells, and regenerating stably transformed fertile plants from the transformed cells.
    Type: Grant
    Filed: March 6, 1997
    Date of Patent: September 21, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Yin-Fu Chang, James Richard Wong, Andrea Itano, Stephen J. Mejza, Leslie Walker
  • Patent number: 5955274
    Abstract: DNA sequences from the Internal Transcribed Spacers of the ribosomal RNA gene region are described for different species and strains of Septoria, Pseudocercosporella, Fusarium and Mycosphaerella. Specific primers from within these sequences are identified as being useful for the identification of the fungal isolates using PCR-based techniques.
    Type: Grant
    Filed: October 15, 1996
    Date of Patent: September 21, 1999
    Assignee: Novartis Finance Corporation
    Inventors: James M. Ligon, James J. Beck
  • Patent number: 5952478
    Abstract: A compound of formula (I) or salts thereof, where R.sup.0 is hydrogen or together with R.sup.7 O denotes a C.sub.1 -C.sub.15 hydrocarbylidenedioxy group, R.sup.1 is hydrogen, R.sup.1.sub.a or a group of formula (II), R.sup.1.sub.a is R.sup.1.sub.b or a protecting group Q, R.sup.1.sub.b is C.sub.1 -C.sub.20 alkyl, C.sub.2 -C.sub.20 alkenyl, C.sub.3 -C.sub.10 cycloalkyl, C.sub.6 -C.sub.15 aryl, C.sub.7 -C.sub.16 aralkyl or a 5- or 6-membered heterocyclic group attached by a carbon atom in the heterocyclic group to the indicated phosphorus atom, R.sup.2 is R.sup.2.sub.a or --OR.sup.15 or together with R.sup.5 denotes an oxy group --O--, provided that R.sup.2 is --OR.sup.15 when R.sup.1 is a group of formula (II), R.sup.2.sub.a is a C.sub.1 -C.sub.20 aliphatic group, a C.sub.3 -C.sub.10 cycloaliphatic group, a C.sub.6 -C.sub.15 aromatic group, a C.sub.7 -C.sub.16 araliphatic group, or a 5- or 6-membered heterocyclic group attached by a carbon atom in the heterocyclic group to the indicated phosphorus atom, R.sup.
    Type: Grant
    Filed: April 14, 1997
    Date of Patent: September 14, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Anthony David Baxter, Roger John Taylor, Stephen Paul Collingwood
  • Patent number: 5945437
    Abstract: Plant-protecting mixtures of active ingredients having a synergistically increased action, wherein component I is a compound having a plant-immunizing action of the formula I ##STR1## in which Z is CN, COOH or a salt thereof, CO--OC.sub.1 -C.sub.4 alkyl or CO--SC.sub.1 -C.sub.4 alkyl;and wherein component II is a compound selected from the group consisting of propiconazole, difenoconazole, penconazole, fenpropimorph, fenpropidine, cyprodinil, metalaxyl, R-metalaxyl and pyroquilon.
    Type: Grant
    Filed: July 16, 1997
    Date of Patent: August 31, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Wilhelm Ruess, Gertrude Knauf-Beiter, Ruth Beatrice Kung, Helmut Kessmann
  • Patent number: 5942662
    Abstract: The present invention provides chemically regulatable DNA sequences capable of regulating transcription of an associated DNA sequence in plants or plant tissues, chimeric constructions containing such sequences, vectors containing such sequences and chimeric constructions, and transgenic plants and plant tissues containing these chimeric constructions. In one aspect, the chemically regulatable DNA sequences of the invention are derived from the 5' region of genes encoding pathogenisis-related (PR) proteins. The present invention also provides anti-pathogenic sequences derived from novel cDNAs coding for PR proteins which can be genetically engineered and transformed into plants to confer enhanced resistance to disease.
    Type: Grant
    Filed: November 14, 1997
    Date of Patent: August 24, 1999
    Assignee: Novartis Finance Corporation
    Inventors: John A. Ryals, Christian T. Harms, Leslie B. Friedrich, James J. Beck, Scott J. Uknes, Eric R. Ward
  • Patent number: 5939602
    Abstract: The present invention provides novel DNA sequences coding for plant protoporphyrinogen oxidase (protox) enzymes from soybean, wheat, cotton, sugar beet, rape, rice and sorghum. In addition, the present invention teaches modified forms of protox enzymes that are herbicide tolerant. Plants expressing herbicide tolerant protox enzymes taught herein are also provided. These plants may be engineered for resistance to protox inhibitors via mutation of the native protox gene to a resistant form or they may be transformed with a gene encoding an inhibitor-resistant from of a plant protox enzyme.
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: August 17, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Sandra L. Volrath, Marie A. Johnson, Eric R. Ward, Peter B. Heifetz
  • Patent number: 5935951
    Abstract: The invention relates to novel 1-acyl-4-aliphatylaminopiperidine compounds of ##STR1## formula (I), in which R.sub.1 is a benzoyl, naphthoyl or cycloalkanoyl radical which is unsubstituted or substituted by lower alkyl, lower alkoxy, halogen and/or trifluoromethyl; R.sub.2 is cycloalkyl or a phenyl or naphthyl radical which is unsubstituted or substituted by lower alkyl, lower alkoxy, halogen, nitro, cyano and/or trifluoromethyl; R.sub.3 and R.sub.4 together are lower alkylene or aza-, oxa- or thia-lower alkylene; or R.sub.3 is lower alkyl, lower alkoxy-lower alky, di-lower alkylamino-lower alkyl or a radical of the formula --(CH.sub.2).sub.n --C(.dbd.O)--R.sub.5 (Ia); and R.sub.4 is hydrogen, lower alkyl or a radical of the formula --(CH.sub.2).sub.n --C(.dbd.O)--R.sub.5 (Ia); R.sub.
    Type: Grant
    Filed: March 5, 1997
    Date of Patent: August 10, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Silvio Ofner, Siem Jacob Veenstra
  • Patent number: 5925744
    Abstract: The present invention relates to cyclic terpyridine-lanthanide complexes having 8 nitrogen atoms and 10 carbon atoms in the macrocycle and containing a functional group in the terpyridine moiety. The invention also relates to a process for the preparation of cyclic terpyridine-lanthanide complexes through the condensation of terpyridine hydrazines with pyridine-2,6-dialdehydes or -ketones. The compounds can be complexed with oligonculeotides and are useful in the sequence-specific cleavage of RNA.
    Type: Grant
    Filed: July 28, 1997
    Date of Patent: July 20, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Robert Haner, Jonathan Hall, Dieter Husken, Uwe Pieles, Heinz Moser
  • Patent number: 5919705
    Abstract: DNA constructs encoding an RNA molecule capable of interacting with an RNA dependent RNA polymerase encoded for by a virus when invading a plant such that either an eliciting element or a plus sense RNA is produced as a consequence of the interaction with the RNA dependent RNA polymerase encoded by the said invading virus, whereby any produced plus sense RNA molecule is capable of encoding for an eliciting element, plants containing such constructs and processes for obtaining such plants.
    Type: Grant
    Filed: December 1, 1995
    Date of Patent: July 6, 1999
    Assignee: Novartis Finance Corporation
    Inventor: Petrus Theodorus de Haan
  • Patent number: 5912352
    Abstract: The invention relates to a novel process for the preparation of compounds of formula I ##STR1## wherein R.sub.1 is hydrogen or a suitable amino-protecting group,R.sub.2 is unsubstituted or substituted alkyl,R.sub.3 is hydrogen, aryl, heterocyclyl, unsubstituted or substituted alkyl or unsubstituted or substituted cycloalkyl,R.sub.4, independently of R.sub.1, is hydrogen or a suitable amino-protecting group andm is a number from 1 to 7; and wherein further suitable protecting groups for functional groups may be present; which compounds are antivirally active or can be used as starting materials for pharmaceutically active, especially antiviral compounds.
    Type: Grant
    Filed: May 30, 1997
    Date of Patent: June 15, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Alexander Fassler, Guido Bold, Hans-Georg Capraro, Heinz Steiner
  • Patent number: 5907084
    Abstract: A nucleotide sequence comprising a transcriptional regulatory sequence and a sequence contiguous therewith and under the transcriptional control thereof, which contiguous sequence encodes an RNA which consists of a plurality of sub-sequences, characterized in that at least two of the sub-sequences have the sequences of viral RNAs and the RNA contains at least one translational stop codon located upstream of the 3' terminal sub-sequence. It is preferred that at least one of the sub-sequences is in an anti-sense configuration with respect to virus RNA, and that the contiguous sequence encodes mRNA. The invention also includes, inter alia, the use of such a sequence in the generation of virus resistant or tolerant plants, and such plants comprising the sequence.
    Type: Grant
    Filed: April 3, 1996
    Date of Patent: May 25, 1999
    Assignee: Novartis Finance Corporation
    Inventor: Petrus Theodorus de Haan
  • Patent number: 5891913
    Abstract: The present invention describes an ophthalmic composition diclofenac potassium, the use of said composition as a medicament for treating inflammatory conditions of the eye, for treating glaucoma or for treating ear inflammatory conditions and/or painful conditions (otitis)-l as well as the use of diclofenac potassium in the preparation of a pharmaceutical composition for the treatment of any inflammatory condition of the eye, for treating glaucoma or for treating ear inflammatory and/or painful conditions (otitis).
    Type: Grant
    Filed: August 27, 1997
    Date of Patent: April 6, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Alfred Sallmann, Gyorgy Lajos Kis, Wolfgang Blum, Alica Huxley